Macdonald R. Loch
Insider CIK 1653008 · GRCE Chief Medical Officer · EDGE Chief Scientific Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GRCE Grace Therapeutics, Inc. | A Award deriv | 2026-08-28 | 2026-09-01 | 54,690 | — | $0 | 54,690 | SEC↗ |
| GRCE Grace Therapeutics, Inc. | A Award deriv | 2026-08-28 | 2026-09-01 | 54,690 | — | $0 | 54,690 | SEC↗ |
| GRCE Grace Therapeutics, Inc. | A Award deriv | 2025-04-14 | 2025-04-16 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ACST Acasti Pharma Inc. | A Award deriv | 2024-05-06 | 2024-05-08 | 25,380 | — | $0 | 25,380 | SEC↗ |
| ACST Acasti Pharma Inc. | A Award deriv | 2023-07-14 | 2023-07-18 | 60,000 | — | $0 | 60,000 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | M Exercise deriv | 2019-03-15 | 2019-03-18 | 10,000 | — | $0 | 0 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | M Exercise | 2019-03-15 | 2019-03-18 | 10,000 | — | $0 | 580,602 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2018-08-14 | 2018-08-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2018-06-19 | 2018-06-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | S Sale | 2018-03-22 | 2018-03-22 | 2,500 | $16.41 | $41.0K | 570,602 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | S Sale | 2018-03-21 | 2018-03-21 | 2,500 | $16.52 | $41.3K | 573,102 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | S Sale | 2018-03-20 | 2018-03-21 | 5,000 | $16.47 | $82.3K | 575,602 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | S Sale | 2018-03-19 | 2018-03-21 | 2,500 | $16.66 | $41.6K | 580,602 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | S Sale | 2018-02-22 | 2018-02-22 | 2,500 | $14.49 | $36.2K | 583,102 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | S Sale | 2018-02-21 | 2018-02-22 | 5,000 | $13.82 | $69.1K | 585,602 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | S Sale | 2018-02-20 | 2018-02-22 | 5,000 | $13.75 | $68.8K | 590,602 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2017-03-13 | 2017-03-15 | 110,000 | $8.86 | $974.6K | 110,000 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | M Exercise deriv | 2017-01-23 | 2017-01-25 | 25,000 | — | $0 | 75,504 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | M Exercise | 2017-01-23 | 2017-01-25 | 25,000 | $2.04 | $51.0K | 595,602 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2016-02-16 | 2016-02-18 | 85,000 | — | $0 | 85,000 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion deriv | 2015-10-06 | 2015-10-08 | 5,373 | — | $0 | 0 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion deriv | 2015-10-06 | 2015-10-08 | 25,000 | — | $0 | 0 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion | 2015-10-06 | 2015-10-08 | 3,928 | — | $0 | 570,408 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion | 2015-10-06 | 2015-10-08 | 18,274 | — | $0 | 566,480 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | J Other | 2015-10-06 | 2015-10-08 | 194 | $7.90 | $1.5K | 570,602 | SEC↗ |